Dr. Ryo Takeuchi, Sr. Director, Genome Editing at Excision, will present on leveraging EBT-101 preclinical and clinical insights for new in vivo multiplex editing programs. Learn more: loom.ly/1IfiuqE

Excision presented data on EBT-107 at the 2024 International HBV Meeting, highlighting its potential to increase Hepatitis B cure rates. Learn more: loom.ly/1IfiuqE

Join us today at 2:30 pm CDT as Dr. Ryo Takeuchi, Senior Director of Genome Editing at Excision, presents on 'Development of Multiplex Gene Editing Therapy for Chronic Hepatitis B' at the 2024 International HBV Meeting. Learn more: loom.ly/1IfiuqE

Today, Excision announced a new publication in Molecular Therapy Methods & Clinical Development on EBT-104 for HSV-1 keratitis treatment. 📍Read the full publication: excision.bio/news/press-rele… #ExcisionBio #MolecularTherapy #HSV #CRISPR #GeneEditing

We're honored to have been awarded one of the 'Fierce 15' Biotech Companies of 2024 by Fierce Biotech. Our unique use of CRISPR/Cas gene editing has recently achieved in vivo proof-of-concept in combating Herpes Virus and Hepatitis B. loom.ly/1IfiuqE #Excision

We're excited to share that Excision BioTherapeutics has been mentioned in a recent article highlighting our Phase 1/2 trial of EBT-101 in HIV and promising preclinical results for herpes and hepatitis B. loom.ly/L8u-X08

Celebrating a successful showcase at #ASGCT2024, Excision Biotherapeutics is proud to have shared our groundbreaking research at the event. We pushed the boundaries of gene therapy, leaving a lasting impact. #Excision #ExcisionBio

Today, Excision BioTherapeutics announced data from our Phase 1/2 Trial of EBT-101 in HIV and In Vivo Efficacy data in Herpes Virus and Hepatitis B. Read our press release: loom.ly/YxPaq_8 #Excision #Excisionbio

TODAY | Join Dr. Rachel Presti for an update on Excision Biotherapeutics’ HIV-1 clinical trial at #ASGCT2024! Discover the transformative potential of our gene editing technologies firsthand. Learn more: loom.ly/aLsEjFo #ExcisionBio #ASGCT #GeneEditing

Mark your calendars for tomorrow, May 10th! Excision Biotherapeutics is gearing up to present our latest advancements in gene editing at #ASGCT2024. Don't miss out on the opportunity to explore the forefront of biotechnology. Visit: loom.ly/aLsEjFo #ExcisionBio #ASGCT